Aker BioMarine ASA (OSL:AKBM)

Norway flag Norway · Delayed Price · Currency is NOK
104.00
-2.40 (-2.26%)
At close: Mar 6, 2026
64.30%
Market Cap 9.12B
Revenue (ttm) 2.20B
Net Income (ttm) -229.84M
Shares Out 87.70M
EPS (ttm) n/a
PE Ratio n/a
Forward PE 40.10
Dividend n/a
Ex-Dividend Date n/a
Volume 8,392
Average Volume 32,464
Open 110.00
Previous Close 106.40
Day's Range 104.00 - 110.00
52-Week Range 43.65 - 110.00
Beta 0.37
RSI 57.14
Earnings Date Feb 12, 2026

About Aker BioMarine ASA

Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. It operates through three segments: Human Health Ingredients (HHI), Consumer Health Products, and Emerging Business. The Human Health Ingredients segment sells B2B krill oil supplements for humans under the Superba Krill brand; supplements for brain health under the LYSOVETA brand; and marine-origin DHA omega-3 from microalgae under the Revervia brand name, as well as advanced phospholipid technology under PL+ name. ... [Read more]

Industry Packaged Foods
Founded 2006
Employees 249
Stock Exchange Oslo Børs
Ticker Symbol AKBM
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

World’s largest krill harvester at centre of row over ‘blue tick’ sustainability label

Aker QRILL is facing criticism of its fishery management amid calls by environmentalists for curbs on Antarctic fishing of the keystone species Environmental groups have objected to the recommendation...

3 days ago - The Guardian

Aker BioMarine ASA (FRA:1PG) Q4 2025 Earnings Call Highlights: Strong Growth in Human Health ...

Aker BioMarine ASA (FRA:1PG) Q4 2025 Earnings Call Highlights: Strong Growth in Human Health Ingredients Amidst Consumer Health Challenges

17 days ago - GuruFocus

Q4 2025 Aker Biomarine ASA Earnings Call Transcript

Q4 2025 Aker Biomarine ASA Earnings Call Transcript

17 days ago - GuruFocus

Aker BioMarine ASA (OSL:AKBM) Q4 2025 Earnings Report Preview: What To Look For

Aker BioMarine ASA (OSL:AKBM) Q4 2025 Earnings Report Preview: What To Look For

24 days ago - GuruFocus

Aker BioMarine ASA (STU:1PG) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...

Aker BioMarine ASA (STU:1PG) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges

4 months ago - GuruFocus

Q3 2025 Aker Biomarine ASA Earnings Call Transcript

Q3 2025 Aker Biomarine ASA Earnings Call Transcript

4 months ago - GuruFocus

Aker BioMarine ASA (OSL:AKBM) Q3 2025 Earnings Report Preview: What To Expect

Aker BioMarine ASA (OSL:AKBM) Q3 2025 Earnings Report Preview: What To Expect

4 months ago - GuruFocus

Aker BioMarine ASA (FRA:1PG) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...

Aker BioMarine ASA (FRA:1PG) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid Operational Challenges

8 months ago - GuruFocus

Q2 2025 Aker Biomarine ASA Earnings Call Transcript

Q2 2025 Aker Biomarine ASA Earnings Call Transcript

8 months ago - GuruFocus

What To Expect From Aker BioMarine ASA (OSL:AKBM) Q4 2024 Earnings

What To Expect From Aker BioMarine ASA (OSL:AKBM) Q4 2024 Earnings

1 year ago - GuruFocus